Outcomes of a multifaceted medication adherence intervention for HIV-positive patients

AIDS Patient Care and STDs

Volumn 21, Issue 2, 2007, Pages 81-91

  Dieckhaus, Kevin D ^a   Odesina, Victoria ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENFUVIRTIDE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ARTICLE; CD4+ T LYMPHOCYTE; EVALUATION; FOLLOW UP; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PATIENT COMPLIANCE; SELF REPORT; STATISTICAL MODEL; VIREMIA;

ADOLESCENT; ADULT; AGED; ANTI-HIV AGENTS; CHILD; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; RNA, VIRAL; VIRAL LOAD;

EID: 33847771150     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2006.0044     Document Type: Article

References (50)

1. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-860.
2. Mannheimer SB, Matts J, Telzak E, et al. Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence. AIDS Care 2005;17:10-22.
3. Bedell SE, Jabbour S, Goldberg R, et al. Discrepancies in the use of medications: Their extent and predictors in an outpatient practice. Arch Intern Med 2000;160: 2129-2134.
4. Stephenson BJ, Rowe BH, Haynes RB, Macharia WM, Leon G. The rational clinical examination. Is this patient taking the treatment as prescribed? JAMA 1993;269:2779-2781.
5. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30.
6. Chesney M. Adherence to HAART regimens. AIDS Patient Care STDs 2003;17:169-177.
7. Wood E, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV, Montaner JS. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD44+ cell count is 0.200 to 0.350 × 10(9) cells/L. Ann Intern Med 2003;139:810-816.
8. Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care 2000;12:255-266.
9. McNabb J, Ross JW, Abriola K, Turley C, Nightingale CH, Nicolau DP. Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic. Clin Infect Dis 2001;33:700-705.
10. Rigsby MO, Rosen MI, Beauvais JE, et al. Cue-dose training with monetary reinforcement: Pilot study of an antiretroviral adherence intervention. J Gen Intern Med 2000;15:841-847.
11. Bova C, Fennie K, Knafl G, Dieckhaus K, Watrous E, Williams A. Use of electronic monitoring devices to measure antiretroviral adherence: Practical considerations. AIDS Behav 2005;9:103-110.
12. Cheever LW, Wu AW. Medication adherence among HIV-infected patients: Understanding the complex behavior of patients taking this complex therapy. Curr Infect Dis Rep 1999;1:401-407.
13. Durante AJ, Bova CA, Fennie KP, et al. Home-based study of anti-HIV drug regimen adherence among HIV-infected women: Feasibility and preliminary results. AIDS Care 2003;15:103-115.
14. Hinkin CH, Hardy DJ, Mason KI, et al. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS 2004;18(Suppl 1):S19-25.
15. Ingersoll K. The impact of psychiatric symptoms, drug use, and medication regimen on non-adherence to HIV treatment. AIDS Care 2004;16:199-211.
16. Wutoh AK, Elekwachi O, Clarke-Tasker V, Daftary M, Powell NJ, Campusano G. Assessment and predictors of antiretroviral adherence in older HIV-infected patients. J Acquit Immune Defic Syndr 2003; 33(Suppl 2):S106-114.
17. Altice FL, Mostashari F, Friedland GH. Trust and the acceptance of and adherence to antiretroviral therapy. J Acquir Immune Defic Syndr 2001;28:47-58.
18. Mannheimer S, Morse A, Matts J, et al. Sustained benefit from a long-term antiretroviral (AR) adherence intervention: Results of a large randomized clinical trial. Paper presented at XV International AIDS Conference, Bangkok, Thailand: July 11-16, 2004.
19. Roberts KJ. Barriers to and facilitators of HIV-positive patients' adherence to antiretroviral treatment regimens. AIDS Patient Care STDs 2000;14:155-168.
20. Nieuwkerk PT, Sprangers MA, Burger DM, et al. Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study. Arch Intern Med 2001;161:1962-1968.
21. Wagner GJ, Ryan GW. Relationship between routinization of daily behaviors and medication adherence in HIV-positive drug users. AIDS Patient Care STDs 2004;18:385-393.
22. Chesney MA, Morin M, Sherr L. Adherence to HIV combination therapy. Soc Sci Med 2000;50:1599-1605.
23. Nieuwkerk PT, Gisolf EH, Colebunders R, Wu AW, Danner SA, Sprangers MA. Quality of life in asymptomatic-and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy. The Prometheus Study Group. AIDS 2000;14:181-187.
24. Mocroft A, Youle M, Moore A, et al. Reasons for modification and discontinuation of antiretrovirals: Results from a single treatment centre. AIDS 2001;15: 185-194.
25. Weiss L, French T, Finkelstein R, Waters M, Mukherjee R, Agins B. HIV-related knowledge and adherence to HAART. AIDS Care 2003;15:673-679.
26. van Servellen G, Nyamathi A, Carpio F, et al. Effects of a treatment adherence enhancement program on health literacy, patient-provider relationships, and adherence to HAART among low-income HIV-positive Spanish-speaking Latinos. AIDS Patient Care STDs 2005;19:745-759.
27. Schneider J, Kaplan SH, Greenfield S, Li W, Wilson IB. Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection. J Gen Intern Med 2004;19:1096-1103.
28. Ammassari A, Murri R, Pezzotti P, et al. Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Defic Syndr 2001;28:445-449.
29. Miller LG, Liu H, Hays RD, et al. How well do clinicians estimate patients' adherence to combination antiretroviral therapy? J Gen Intern Med 2002;17:1-11.
30. Bangsberg DR, Hecht FM, Clague H, et al. Provider assessment of adherence to HIV antiretroviral therapy. J Acquir Immune Defic Syndr 2001;26):435-442.
31. Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 1999;21:1074-1090; discussion 1073.
32. Gross R, Zhang Y, Grossberg R. Medication refill logistics and refill adherence in HIV. Pharmacoepidemiol Drug Saf 2005;14:789-793.
33. Wendel CS, Mohler MJ, Kroesen K, Ampel NM, Gifford AL, Coons SJ. Barriers to use of electronic adherence monitoring in an HIV clinic. Ann Pharmacother 2001;35:1010-1015.
34. Arnsten JH, Demas PA, Farzadegan H, et al. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring. Clin Infect Dis 2001;33: 1417-1423.
35. Hugen PW, Langebeek N, Burger DM, et al. Assessment of adherence to HIV protease inhibitors: comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse report, and therapeutic drug monitoring. J Acquir Immune Defic Syndr 2002;30:324-334.
36. Melbourne KM, Geletko SM, Brown SL, Willey-Lessne C, Chase S, Fisher A. Medication adherence in patients with HIV infection: A comparison of two measurement methods. AIDS Read 1999;9: 329-338.
37. Giordano TP, Guzman D, Clark R, Charlebois ED, Bangsberg DR. Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials 2004;5:74-79.
38. Liu H, Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med 2001;134:968-977.
39. Hill Z, Kendall C, Fernandez M. Patterns of adherence to antiretrovirals: Why adherence has no simple measure. AIDS Patient Care STDs 2003;17:519-525.
40. Van Wijngaerden E, De Saar V, De Graeve V, et al. Nonadherence to highly active antiretroviral therapy: Clinically relevant patient categorization based on electronic event monitoring. AIDS Res Hum Retroviruses 2002;18:327-330.
41. Wilson IB, Tchetgen E, Spiegelman D. Patterns of adherence with antiretroviral medications: An examination of between-medication differences. J Acquir Immune Defic Syndr 2001;28:259-263.
42. Trotta MP, Ammassari A, Melzi S, et al. Treatment-related factors and highly active antiretroviral therapy adherence. J Acquir Immune Defic Syndr 2002;31 (Suppl 3):S128-131.
43. Murphy DA, Lu MC, Martin D, Hoffman D, Marelich WD. Results of a pilot intervention trial to improve antiretroviral adherence among HIV-positive patients. J Assoc Nurses AIDS Care 2002;13:57-69.
44. Levy RW, Rayner CR, Fairley CK, et al. Multidisciplinary HIV adherence intervention: a randomized study. AIDS Patient Care STDs 2004;18:728-735.
45. Kalichman SC, Cain D, Cherry C, Kalichman M, Pope H. Pillboxes and antiretroviral adherence: Prevalence of use, perceived benefits, and implications for electronic medication monitoring devices. AIDS Patient Care STDs 2005;19:833-839.
46. Rathbun RC, Farmer KC, Stephens JR, Lockhart SM. Impact of an adherence clinic on behavioral outcomes and virologic response in treatment of HTV infection: A prospective, randomized, controlled pilot study. Clin Ther 2005;27:199-209.
47. Simoni JM, Frick PA, Pantalone DW, Turner BJ. Antiretroviral adherence interventions: A review of current literature and ongoing studies. Top HIV Med 2003;11:185-198.
48. Parry MF, Wright P, Stewart J, McLeod GX, Tucker J, Wienburg AR. Impact of an adherence program on the health and outlook of HIV-infected patients failing antiretroviral therapy. J Int Assoc Physicians AIDS Care 2005;4:59-65.
49. Albus C, Schmeisser N, Salzberger B, Fatkenheuer G. Preferences regarding medical and psychosocial support in HIV-infected patients. Patient Educ Couns 2005;56:16-20.
50. Goldie SJ, Paltiel AD, Weinstein MC, et al. Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection. Am J Med 2003;115:632-641.